| Literature DB >> 26550268 |
Yuhong Li1, Rong Wu2, Yian Tian3, Min Yu1, Yun Tang1, Huaipin Cheng1, Zhaofang Tian1.
Abstract
Lipopolysaccharide (LPS) is known to induce acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Accumulating data suggest the crucial role of RAGE in the pathogenesis of ALI/ARDS. However, the mechanism by which RAGE mediates inflammatory lung injury in the neonates remains elusive. In this study we established LPS-induced ALI model in neonate rats, and investigated the role of RAGE/NF-κB signaling in mediating ALI. We found that RAGE antibody or bortezomib reduced LPS-induced histopathological abnormalities in the lung and lung damage score. RAGE antibody or bortezomib also reduced TNF-α level in both serum and BALF of the rats. Furthermore, RAGE antibody or bortezomib significantly reduced LPS-induced upregulation of RAGE and NF-κB expression in the lung. In conclusion, we established ALI model in neonate rats to demonstrate that LPS induced inflammatory lung injury via RAGE/NF-κB signaling. Interference with RAGE/NF-κB signaling is a potential approach to prevent and treat sepsis-related ALI/ARDS.Entities:
Keywords: Acute lung injury; NF-κB; RAGE; bortezomib; neonate
Year: 2015 PMID: 26550268 PMCID: PMC4612953
Source DB: PubMed Journal: Int J Clin Exp Med ISSN: 1940-5901